Avenue Net Borrowings from 2010 to 2025

ATXI Stock  USD 1.95  0.04  2.01%   
Avenue Therapeutics' Net Borrowings is decreasing with slightly volatile movements from year to year. Net Borrowings is estimated to finish at about -5 M this year. Net Borrowings is the difference between the amount of new debt Avenue Therapeutics has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2010-12-31
Previous Quarter
-5.3 M
Current Value
-5 M
Quarterly Volatility
5.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avenue Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avenue Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 165.9 K, Depreciation And Amortization of 17.6 M or Interest Expense of 350.7 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.02. Avenue financial statements analysis is a perfect complement when working with Avenue Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Avenue Therapeutics Correlation against competitors.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.

Latest Avenue Therapeutics' Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Avenue Therapeutics over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Avenue Therapeutics' Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avenue Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Slightly volatile
   Net Borrowings   
       Timeline  

Avenue Net Borrowings Regression Statistics

Arithmetic Mean(1,379,026)
Coefficient Of Variation(369.30)
Mean Deviation4,848,500
Median(5,000,040)
Standard Deviation5,092,765
Sample Variance25.9T
Range10.4M
R-Value(0.86)
Mean Square Error7.2T
R-Squared0.74
Significance0.000018
Slope(921,087)
Total Sum of Squares389T

Avenue Net Borrowings History

2025-5 M
2024-5.3 M
2017-5.8 M
20161.9 M

About Avenue Therapeutics Financial Statements

Investors use fundamental indicators, such as Avenue Therapeutics' Net Borrowings, to determine how well the company is positioned to perform in the future. Although Avenue Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Borrowings-5.3 M-5 M

Currently Active Assets on Macroaxis

When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:
Check out the analysis of Avenue Therapeutics Correlation against competitors.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
24.78
Return On Assets
(2.01)
Return On Equity
(5.35)
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.